Fatty acid derivative anticonvulsants

93 7439 Pill - orange oval, 12mm

Pill with imprint 93 7439 is Orange, Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Teva Pharmaceuticals USA.

Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Epilepsy; Migraine Prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Divalproex sodium (Divalproex sodium [ dye-val-pro-ex ])-93 7439-125 mg-Orange-Oval
Divalproex sodium (Divalproex sodium [ dye-val-pro-ex ])-93 7439-125 mg-Orange-Oval

Divalproex sodium
Generic Name: divalproex sodium [ dye-val-pro-ex ]
Imprint: 93 7439
Strength: 125 mg
Color: Orange
Size: 12.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00093-7439 (Discontinued)
Inactive Ingredients: Hypromellose 2910 (15 mPa.s), Ferrosoferric oxide, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol 3350, Polyethylene glycol 4000, Povidone k30, Corn starch, Propylene glycol, Shellac, Silicon dioxide, Magnesium silicate, Titanium dioxide, Triethyl citrate, D&C Yellow No. 10, FD&C Red No. 40, FD&C Yellow No. 6,
Latest News
Related Drugs